EliA Celikey IgA Well

The EliA Celikey IgA Test permits the determination of IgA antibodies directed against the tTG antigen as described in the directions for use.

Catalog Number	Quantity
14-5517-01	4 x 12

Catalog number 14-5517-01

Price (EUR)

Quantity:

4 x 12

Celiac disease is a lifelong condition in which ingestion of gluten, the water insoluble wheat gliadin and the prolamins in rye and barley leads to chronic inflammation and damage of the small intestinal mucosa. Tissue transglutaminase (tTG) has been identified as the major autoantigen in celiac disease.

The alcohol-soluble polypeptides of gluten, the gliadins, are responsible for the toxic effects on the intestinal mucosa.

Antibodies directed to tissue transglutaminase and antibodies directed to gliadin are used as serological tests for celiac disease.

EliA is an enzyme immunoassay to measure autoantibodies in blood and serum and runs on these fully automated scalable systems: Phadia 100, Phadia 250, Phadia 2500 and Phadia 5000.

Rx only. CLIA Complexity: Moderate

Available in select countries only.

Please refer to Directions for Use

Specifications

CodeAcy

Cut-OffNegative: < 7 EliA U/mL; Equivocal: 7-10 EliA U/mL; Positive: > 10 EliA U/mL

For Use With (Equipment)Phadia 100, 250, 2500 and 5000

Intended UseIntended for the in vitro quantitative measurement of IgA antibodies directed to tissue transglutaminase (tTG) in human serum and plasma. EliA Celikey IgA is based on recombinant human tissue transglutaminase as antigen and is useful as an aid in the clinical diagnosis of patents with celiac disease. For detail on the definition of use visit the DFU database.

Product NameEliA Celikey IgA Well

Quantity4 x 12

Regulatory Write-InCE Marked

Scientific Namehuman recombinant tissue transglutaminase (tTG)

Unit SizeEach